Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

SQZ - SQZ Biotechnologies Co

Previous close
0.45
0.450   100.000%

Share volume: 0
Last Updated: Mon 03 Jul 2023 05:01:37 PM CEST
Biological Product (except Diagnostic) Manufacturing : -4.32%

PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
76%
Profitability 93%
Dept financing 25%
Liquidity 0%
Performance 90%
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
-34.29%
6 Months
-37.84%
1 Year
-37.84%
2 Year
-96.99%
Key data
Stock price
$0.45
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$0.02 - $0.10
52 WEEK CHANGE
-$37.84
MARKET CAP 
12.829 M
YIELD 
N/A
SHARES OUTSTANDING 
29.491 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
N/A
AVERAGE 30 VOLUME 
N/A
Company detail
CEO:
Region: US
Website: sqzbiotech.com
Employees: 53
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Biological Product (except Diagnostic) Manufacturing
Sector: Manufacturing

spun out of mit, sqz biotechnologies is developing the next generation of cell therapies, using its propriety technology to harness the power of the patient's immune system to combat disease. sqz: empower cells to change lives.

Recent news